InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the full record of transactions filed by Goldstein Michael H., Président, Ophtalmologie et Directeur Médical. Officer active across 2 companies, notably OCULAR THERAPEUTIX, INC. Cumulatively, 1 reports have been recorded. Activity tracked since 3 February 2022. The latest transaction was filed on 3 February 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Michael H. Goldstein is the President of Ophthalmology and Chief Medical Officer at Ocular Therapeutix, Inc. He oversees the company's clinical and research initiatives. With expertise in the healthcare sector, he plays a key role in developing new therapies and improving patient care.